| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 414,7 k € | +11.0% | 373,5 k € | +25.4% | 297,8 k € | +20.5% | 247,1 k € | +284.6% | 64,2 k € | +118.7% | 29,4 k € | +26.9% | 23,1 k € | -76.1% | 96,7 k € | +53.3% | 63,1 k € | -42.6% | 109,9 k € | +0.7% | 109,2 k € | +44.1% | 75,7 k € | -36.1% | 118,6 k € | |
| EBITDA | 412,9 k € | +11.0% | 372,0 k € | +25.4% | 296,6 k € | +20.7% | 245,7 k € | +288.8% | 63,2 k € | +125.0% | 28,1 k € | +29.3% | 21,7 k € | -77.2% | 95,3 k € | +53.3% | 62,2 k € | -43.1% | 109,2 k € | +0.8% | 108,3 k € | +44.4% | 75,0 k € | -35.6% | 116,5 k € | |
| Operating profit | 386,3 k € | +11.7% | 345,8 k € | +26.8% | 272,7 k € | +12.9% | 241,5 k € | +325.7% | 56,7 k € | +156.0% | 22,2 k € | +97.8% | 11,2 k € | -86.6% | 83,4 k € | +44.3% | 57,8 k € | -43.3% | 101,8 k € | +5.2% | 96,8 k € | +42.7% | 67,8 k € | -31.9% | 99,6 k € | |
| Profit/loss | 308,8 k € | +13.7% | 271,6 k € | +26.6% | 214,5 k € | +17.2% | 183,0 k € | +283.5% | 47,7 k € | +126.9% | 21,0 k € | +97.1% | 10,7 k € | -83.1% | 63,3 k € | +63.0% | 38,8 k € | -36.0% | 60,7 k € | -2.6% | 62,3 k € | +42.5% | 43,8 k € | -33.6% | 65,9 k € | |
| Equity | 1,0 M € | +22.6% | 855,1 k € | +46.5% | 583,6 k € | +16.6% | 500,6 k € | +57.6% | 317,6 k € | +17.7% | 269,9 k € | -24.1% | 355,7 k € | +2.9% | 345,8 k € | +21.8% | 284,0 k € | +15.8% | 245,1 k € | +32.9% | 184,4 k € | +51.1% | 122,1 k € | +55.9% | 78,3 k € | |
| Total assets | 1,2 M € | +35.2% | 882,9 k € | +19.8% | 736,9 k € | +10.6% | 666,1 k € | +56.8% | 424,8 k € | +15.5% | 367,9 k € | -3.6% | 381,5 k € | +5.3% | 362,4 k € | +12.7% | 321,5 k € | -6.7% | 344,5 k € | +35.6% | 254,0 k € | +33.3% | 190,5 k € | +58.6% | 120,1 k € | |
| Cash | 349,8 k € | -2.2% | 357,5 k € | +85.4% | 192,9 k € | -10.6% | 215,9 k € | +64.7% | 131,1 k € | +1.7% | 128,9 k € | +91.6% | 67,3 k € | -20.7% | 84,9 k € | +29.5% | 65,6 k € | -30.0% | 93,7 k € | +876.4% | 9,6 k € | -75.6% | 39,3 k € | +115.2% | 18,3 k € | |
| Debts | 128,2 k € | +883.1% | 13,0 k € | -90.2% | 133,3 k € | -14.6% | 156,2 k € | +45.6% | 107,2 k € | +9.4% | 98,1 k € | +280.5% | 25,8 k € | +55.9% | 16,5 k € | -56.0% | 37,6 k € | -62.2% | 99,4 k € | +42.8% | 69,6 k € | +1.7% | 68,4 k € | +63.6% | 41,8 k € | |
Private limited company · Hasselt · incorporated on 20/03/2012
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR JOYCE PENNINGS is a Private limited company incorporated in 2012. Its main activity is: General medical practice activities. Its registered office is in Hasselt.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette